A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine...
A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
•We have generated a bivalent LAIV against H3N8 and H3N2 CIVs.•The bivalent CIV LAIV is safe and protects against WT H3N8 and H3N2 CIVs.•The bivalent CIV LAIV induce better protection than a bivalent CIV IIV.•This is the first description of a bivalent LAIV for the prevention of CIVs.
Canine influenza viruses (CIVs) cause a contagious respirator...
Alternative Titles
Full title
A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1920194694
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1920194694
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2017.06.060
